Implant Sciences get grant for spinal cancer therapy:
This article was originally published in Clinica
Executive Summary
Implant Sciences has gained a $750,000 phase II grant from the US National Institutes of Health (NIH) to continue developing and testing its radioactive plaque technology for treating cancers of the thoracic and lumbar spine. Specifically, the plaque is designed to treat the sarcoma cells on the dural surface without subjecting the spinal cord to harmful doses, says the Wakefield, Massachusetts firm. The award will provide funding for over the next 24 months. Improvements will be made to a prototype of radioactive plaque device, and the resulting product will be assessed in a human trial in collaboration with Massachusetts General Hospital.